Filtered by category "Legislation"

Retail Momentum Gathers for CBD Topicals While FDA Decides Its Direction

By William Sumner, Hemp Business Journal Contributor Hemp-derived CBD is all the rage right now, even as confusion and illegality abound. Prompted by the passage of the 2018 Farm Bill, which legalized hemp and hemp derivatives like CBD, investors and entrepreneurs have been scrambling to capitalize on the increasingly popular substance. The United States Food and Drug Administration […]
Read more

U.S. Medical Cannabis Patients

In its first 11 months, Oklahoma’s medical-cannabis patient registration has outpaced the rates among all other legal states. Unlike in California’s statewide legal adult-use market, Oklahoma expects nearly full participation by its registrants due to much less access either to legal cannabis or illicit markets. While California has the U.S.’s highest patient-saturation rate, its legalized [...]
Read more

More Growth, Consolidation, and M&A Expected for Hemp Industry in 2019

By William Sumner, Hemp Business Journal Contributor From acquisitions to equity investments, the North American hemp industry has been awash in capital investment since the Farm Bill 2018 was federally passed in the United States last December. In the rush for first-mover advantages, entrepreneurs and investors have been scrambling for respective footholds in the nascent hemp market; even [...]
Read more

EFSA’s CBD Novel Food Classification

By Bill Griffin New Frontier Data contributor The emerging European cannabidiol (CBD) market has been thrown into disarray since January 2019 over a change to CBD’s classification by the European Food Safety Authority (EFSA). Here we look at what changed and explore options for those companies impacted. What changed? Before January 2019, the entry for […]
Read more

State of the Cannabis Union July 2019

With Kansas now accepting low-THC/high-CBD products for limited medical purposes, 47 states have legalized some form of cannabis. Approximately 98.6% of U.S. citizens live in states permitting some form of cannabis. In the U.S. House of Representatives, 296 of 435 members (68%) represent medical or adult-use states. In the U.S. Senate, 22% of members represent […]
Read more

As Summer Heats Up, So Too Does Market Buzz About Hemp and CBD Products

By William Sumner, Hemp Business Journal Contributor, and J.J. McCoy, Senior Managing Editor, New Frontier Data The Fourth of July is traditionally a time of celebration without partisanship, a national holiday marked by firing up the grill, watching fireworks, and commemorating the founding of the United States. Less familiar are the ways by which hemp was historically utilized […]
Read more

U.S. Cannabis Usage

Cannabis use in the U.S. has risen 50% since 2009, to 9.9% in 2017, reflecting rapidly evolving public attitudes toward cannabis, as the stigma has eroded, the majority of states have advanced cannabis reform, and science has validated the plant’s diverse therapeutic and industrial properties. Cannabis use has been highly correlated to legalization, with the […]
Read more

European Hemp Market Offers Major Obstacles Along with Speculative Rewards

By William Sumner, Hemp Business Journal Contributor While much has been made about the nascent hemp markets in the United States and Canada, the European market has proven to be enticing on its own: The Hemp Business Journal estimates that by 2020 Europe will see approximately $1.5 billion in sales, whereas the U.S. market is respectively expected to […]
Read more

Potential Zimbabwe Healthcare Savings

Zimbabwe annually spends more than $400 million on health care (based on 2019 budget figures). 25% of all health care spending comes out of pocket (OOP). With a conservative roll-out of a medical cannabis program, Zimbabwe could reduce health-care spends by $10 million by its fifth year. Based on a 10% reduction of health-care spends […]
Read more

Much About CBD Remains TBD as FDA Crafts Food, Supplements Policy

By William Sumner, Hemp Business Journal Contributor While federal regulators consider whether to classify cannabidiol (CBD) as a pharmaceutical ingredient or allow its use as a nutritional supplement, individual states are making moves to decide the issue for themselves. In the state of California, a bill is working its way through the state legislature to make it legal […]
Read more
Top